Theranexus Logo

Theranexus

ISIN: FR0013286259 | Ticker: ALTHX | LEI: 969500BFCV6IC7MFQP20
Sector: Health CareSub-Industry: Biotechnology
Country: France

About Theranexus

Company Description

Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells.

Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.

Year founded

2013

Served area

Worldwide

Headquarters

Pépinière Laennec 60 Avenue Rockefeller, 69008 Lyon – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FR0013286259

LEI

969500BFCV6IC7MFQP20

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.